Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
540K
-
Shares change
-
+172K
-
Total reported value, excl. options
-
$1.48M
-
Value change
-
+$473K
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$2.73
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q1 2022
12 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q1 2022.
HCW Biologics Inc. - COM (HCWB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 540K shares
.
Largest 10 shareholders include HighTower Advisors, LLC (216K shares), VANGUARD GROUP INC (82.5K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (56.6K shares), GEODE CAPITAL MANAGEMENT, LLC (53.2K shares), TWO SIGMA INVESTMENTS, LP (51.2K shares), BlackRock Inc. (39.6K shares), STATE STREET CORP (20.5K shares), Cresset Asset Management, LLC (17.6K shares), UBS Group AG (1.71K shares), and Focused Wealth Management, Inc (1K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.